A new era of precision diagnostics and therapy for patients with neuroendocrine neoplasms began with the approval of somatostatin receptor (SSTR) radiopharmaceuticals for PET imaging followed by ...
Journal of Nuclear Medicine January 2026, jnumed.125.271410; DOI: https://doi.org/10.2967/jnumed.125.271410 ...
The evolution of peptidomimetic hybrid molecules for preoperative imaging and guided surgery targeting the prostate-specific membrane antigen (PSMA) significantly progressed over the past few years, ...
The principle of pretargeted radioimmunoimaging and therapy has been investigated over the past 30 y in preclinical and clinical settings with the aim of reducing the radiation burden of healthy ...
Prostate-specific membrane antigen (PSMA), expressed by most prostate carcinomas (PCa), is a promising target for PCa imaging. The application of PSMA-specific 18F-labeled PET probes such as ...
Nanoparticles possess unique features that may be useful for disease diagnosis and therapy. Preclinically, many different nanodiagnostics have been explored, but only a few have made it to the market.
Scintillation camera images contain a large amount of Poisson noise. We have investigated whether noise can be removed in whole-body bone scans using convolutional neural networks (CNNs) trained with ...
Radiolabeled fibroblast activation protein (FAP) inhibitors (FAPIs) have shown promise as cancer diagnostic agents; however, the relatively short tumor retention of FAPIs may limit their application ...
Journal of Nuclear Medicine November 2024, jnumed.124.268807; DOI: https://doi.org/10.2967/jnumed.124.268807 ...
Respiratory motion during PET acquisition may lead to blurring in resulting images and errors in quantification (1,2). Areas in the upper abdomen and thorax are particularly adversely affected. In the ...
Lung cancer is the most common cause of death among oncologic patients worldwide (1). Resection is the treatment of choice for early-stage non–small cell lung cancer (2). Because of a common risk ...